Astrazeneca solution for injection - AstraZeneca, CoronaVac receive conditional approval as booster dose

On November 18, 2020, published a study review that describes this vaccine's safety and immunogenicity in a broader range of participants, including adults aged 70 years and older.

Remdesivir solution for injection Antivirals for systemic use, for human use 2020-07-27 Food and Drug Regulations Issued Notice of Compliance under the Gilead Sciences Canada Inc.

The vaccine was well-tolerated, and the independent data safety monitoring board identified no safety concerns related to the vaccine.

With a floor area of 2,200 square meters, the facility has an annual production capacity of 400 million doses.